News

April 12, 2017

Ganaxolone Inhibits Neural Processes in Brain Linked to Seizures, Trial Shows

News

Marinus Pharmaceuticals’ ganaxolone inhibited neural processes in the brain that, when unchecked, can trigger epileptic seizures, according to a Phase 1 clinical trial. The results suggest ganaxolone could become a ... Read more

April 10, 2017

Q-State and UCB Partnering on Precision Genetic Therapies for Epilepsy

News

Q-State Biosciences (Q-State) and UCB have agreed to work together on precision genetic therapies for epilepsy, particularly children forms that can be very severe. The collaboration will cover research costs, preclinical ... Read more

April 7, 2017

Researchers Working on Non-Invasive Method to Suppress Epileptic Seizures

News

Researchers at Carnegie Mellon University have developed a new device that detects ongoing epileptic seizures and suppresses them as they start, according to a recent study. This approach may evolve into a ... Read more

April 5, 2017

Europe Grants Orphan Drug Status to Epidiolex to Treat Severe Form of Children’s Epilepsy

News

The European Union has granted orphan drug status to the cannabinoid therapy Epidiolex to treat Lennox-Gestaut syndrome (LGS), a treatment-resistant, childhood-onset form of epilepsy. Epidiolex, GW Pharmaceuticals‘ lead cannabinoid (CBD) product candidate, is a proprietary ... Read more

April 3, 2017April 3, 2017

First Epilepsy Clinical Trial Patients Implanted with Dose-delivering Prometra II Device

News

The first refractory epilepsy patients have been implanted with Prometra II programmable infusion pumps for a clinical trial of the dose-delivery devices, according to the product’s developers, Flowonix Medical and Cerebral Therapeutics. Dan ... Read more

March 31, 2017

Cannabis Product Reduces Epileptic Seizures in Lennox-Gastaut Syndrome, Study Shows

News

A medical cannabis product called RSHO-X dramatically reduced epileptic seizures in a Mexican study of Lennox-Gastaut syndrome, a severe form of childhood epilepsy that responds poorly to treatment. The study ... Read more

March 29, 2017March 29, 2017

Zynerba Completes Enrollment for Two Phase 2 Trials of ZYN002 for Epilepsy and Osteoarthritis

News

Zynerba Pharmaceuticals has completed enrollment in two Phase 2 clinical trials evaluating ZYN002 cannabidiol (CBD) gel in adults with epilepsy and osteoarthritis. Cannabidiol is a non-psychoactive cannabinoid. Naturally occurring cannabinoids ... Read more

March 27, 2017March 27, 2017

Myelin Loss May Trigger Epileptic Seizures in MS, Mouse Study Suggests

News

Scientists at the University of California-Riverside think they know why patients with multiple sclerosis (MS) are up to six times more likely to suffer from epilepsy. The newfound link may lead to the ... Read more

March 24, 2017March 24, 2017

11th National Walk for Epilepsy Fundraiser Is March 25 in Washington, DC

News

The Epilepsy Foundation is hosting the 11th National Walk for Epilepsy on Saturday, March 25, leading the fight to overcome the challenges of living with epilepsy and to raise funds for faster ... Read more

March 22, 2017March 22, 2017

Physician-Family Panel Recommends Actions to Better Diagnose, Treat Dravet Syndrome

News

Thirteen specialists in epilepsy and Dravet syndrome, along with five family members of children with the disease, have jointly developed a set of recommendations for better diagnosis and management of the ... Read more